154.059998 USD
1.26
0.82%
Last update Dec 15, 3:59 PM EST
Pre-market
Day range
151.12000
155.55000
Previous close
152.80000
Open
152.78000
Access this stock data via API
Subscribe
Neurocrine Biosciences Inc.
154.06
1.26
0.82%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 2.4B 1.9B 1.5B 1.1B
Cost of revenue 34M 39.7M 23.2M 14.3M
Gross profit 2.3B 1.8B 1.5B 1.1B
Operating expense
Research & development 731.1M 565M 463.8M 328.1M
Selling general and admin 1.0B 887.6M 752.7M 583.3M
Other operating expenses
Operating income 583M 394.8M 249M 207.8M
Non operating interest income
Income 91M
Expense 126.6M 4.6M 7.1M 25.8M
Other income expense -61.4M -58.1M -28M -80.6M
Pretax income 486M 332.1M 213.9M 101.4M
Tax provision 144.7M 82.4M 59.4M 11.8M
Net income 341.3M 249.7M 154.5M 89.6M
Basic EPS 3.4 2.6 1.6 1.0
Diluted EPS 3.3 2.5 1.6 0.9
Basic average shares 100.4M 97.7M 95.8M 94.6M
Diluted average shares 100.4M 97.7M 95.8M 94.6M
EBITDA 701.1M 416.1M 264.6M 218.7M
Net income from continuing op. 341.3M 249.7M 154.5M 89.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 5 hours 15 minutes

04:14
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).